BALTIMORE--(BUSINESS WIRE)-- TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (formerly MyMD Pharmaceuticals, Inc.) (the “Company”), a clinical stage biopharmaceutical company committed to developing novel ...
BlackRock files for Nasdaq 100 ETF under ticker IQQ, threatening Invesco's decades-long monopoly on U.S. Nasdaq 100 index ...
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results